The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.


Updates from The Motley Fool

Latest updates on Amarin from Fool.com.  The Fool has written over 300 articles on Amarin.
7 Top Stocks to Buy in March

After suffering through a historically bad start to the year through the first half of February, ...

Why Amarin Corp Plc Slumped Today

Although we don't believe in   timing the market or panicking over market movements, we do like t...



Stock Performance

View Interactive AMRN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Amarin.
Current Price: $3.22
Prev Close: $3.24
Open: $3.25
Bid: $3.23
Ask: $3.24
Day's Range: $3.15 - $3.26
52wk Range: $1.24 - $3.65
Volume: 301,912
Avg Vol 2,623,457
Market Cap: $591M
P/E (ttm): -7.53
EPS (ttm): ($0.43)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Amarin.
CAPS Rating 3 out of 5
 
299 Outperform
27 Underperform
CAPS All Stars
 
27 Outperform
6 Underperform

How do you think Amarin will perform against the market?



You pick for Amarin is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph S. (Joe) Zakrzewski, CEO

24% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Amarin.

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers